"We're so close." Dr. Miriam Merad says NIH cuts could derail life-saving cancer research just as scientists close in on new ...

The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.

Researchers have shown how a type of macrophage protects insulin-producing cells in the pancreas from T cells, preventing ...

Many advanced cancers develop resistance to treatment and become highly aggressive, often leaving patients with limited ...

Emapalumab-lzsg is a monoclonal antibody that binds to and neutralizes interferon gamma, a key cytokine in the development of MAS. The Food and Drug Administration (FDA) has granted Fast Track ...

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...

EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in ...